0363-0600 NDC - LOW DOSE ASPIRIN ()

Drug Information

  • Product NDC: 0363-0600
  • Proprietary Name: Low Dose Aspirin
  • Non Proprietary Name:
  • Active Ingredient(s):
  • Administration Route(s):
  • Dosage Form(s):

Labeler Information

Field Name Field Value
Labeler Name: WALGREEN CO.
Product Type:
FDA Application Number: part343
Marketing Category: OTC MONOGRAPH NOT FINAL
Start Marketing Date:2/12/2008
End Marketing Date:4/18/2013

Package Information

No. Package Code Package Description Billing Unit
10363-0600-011 BOTTLE in 1 CARTON (0363-0600-01) / 70 TABLET, FILM COATED in 1 BOTTLE
20363-0600-135 BLISTER PACK in 1 CARTON (0363-0600-13) / 1 TABLET, FILM COATED in 1 BLISTER PACKEA
30363-0600-17300 TABLET in 1 BOTTLE, PLASTIC (0363-0600-17)
40363-0600-2215 BLISTER PACK in 1 CARTON (0363-0600-22) / 1 TABLET, FILM COATED in 1 BLISTER PACKEA
50363-0600-271 BOTTLE in 1 CARTON (0363-0600-27) / 32 TABLET in 1 BOTTLE
60363-0600-291 BOTTLE in 1 CARTON (0363-0600-29) / 150 TABLET in 1 BOTTLE
70363-0600-321 BOTTLE in 1 CARTON (0363-0600-32) / 120 TABLET in 1 BOTTLE
80363-0600-331 BOTTLE in 1 CARTON (0363-0600-33) / 60 TABLET, FILM COATED in 1 BOTTLE
90363-0600-391 BOTTLE in 1 CARTON (0363-0600-39) / 30 TABLET, FILM COATED in 1 BOTTLEEA
100363-0600-471 BOTTLE in 1 CARTON (0363-0600-47) / 150 TABLET, FILM COATED in 1 BOTTLE
110363-0600-491 BOTTLE in 1 CARTON (0363-0600-49) / 40 TABLET, FILM COATED in 1 BOTTLE
120363-0600-751 BOTTLE in 1 CARTON (0363-0600-75) / 90 TABLET, FILM COATED in 1 BOTTLEEA
130363-0600-951 BOTTLE in 1 CARTON (0363-0600-95) / 45 TABLET, FILM COATED in 1 BOTTLEEA
140363-0600-99500 TABLET in 1 BOTTLE (0363-0600-99)EA

NDC Record

Field Name Field Value Definition
PRODUCT NDC0363-0600The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMEWal Fex 24 Hour AllergyThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
START MARKETING DATE3/6/2014This is the date that the labeler indicates was the start of its marketing of the drug product.
END MARKETING DATE4/30/2023This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
MARKETING CATEGORY NAMEANDAProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
APPLICATION NUMBERANDA076447This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAMEWalgreen CompanyName of Company corresponding to the labeler code segment of the Product NDC.
PRODUCT NDC0363-0600The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMELow Dose AspirinThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
START MARKETING DATE2/12/2008This is the date that the labeler indicates was the start of its marketing of the drug product.
END MARKETING DATE4/18/2013This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
MARKETING CATEGORY NAMEOTC MONOGRAPH NOT FINALProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
APPLICATION NUMBERpart343This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAMEWALGREEN CO.Name of Company corresponding to the labeler code segment of the Product NDC.

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 12/6/2025

Previous Code
Next Code